Phibro Animal Health CorporationPAHCNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank80
3Y CAGR+12.5%
5Y CAGR+3.1%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+12.5%/yr
vs -5.5%/yr prior
5Y CAGR
+3.1%/yr
Recent acceleration
Acceleration
+18.0pp
Accelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM15.43%+36.2%
202511.33%+66.9%
20246.79%-37.4%
202310.84%-12.8%
202212.43%-6.0%
202113.23%+4.2%
202012.69%-6.8%
201913.62%-13.2%
201815.68%-2.9%
201716.15%-